Osilodrostat
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 143 publications
Efficacy and safety of osilodrostat for the treatment of Cushing's syndrome
Journal: Zhonghua nei ke za zhi
Published: January 08, 2026
Osilodrostat for Bilateral Adrenal Hypercortisolism in Primary Aldosteronism.
Journal: The New England journal of medicine
Published: November 26, 2025
Controlling cortisol excess and comorbidities in Cushing's syndrome with osilodrostat.
Journal: Pituitary
Published: October 13, 2025
The effect of hypercortisolism treatment on dyslipidemia in Cushing syndrome: systematic review and meta-analysis.
Journal: The Journal of clinical endocrinology and metabolism
Published: September 26, 2025
Real-World Data on the Efficacy and Safety of Osilodrostat in Patients with Cushing's Disease in Spain.
Journal: Journal of clinical medicine
Published: September 23, 2025
Case Report: Ectopic Cushing's syndrome caused by a pancreatic neuroendocrine tumor managed through dual steroidogenesis inhibition and endoscopic ultrasound-guided ethanol ablation.
Journal: Frontiers in endocrinology
Published: September 06, 2025
Blood steroid hormone profile and clinical outcomes following switching from metyrapone to osilodrostat in patients with Cushing disease.
Journal: Endocrine journal
Published: August 31, 2025
Clinical management of ectopic Cushing Syndrome in neuroendocrine neoplasms: a national survey.
Journal: Frontiers in endocrinology
Published: August 22, 2025
Adverse Event Profile Differences Between Metyrapone and Osilodrostat: A Pharmacovigilance Study of the FDA Adverse Event Reporting System.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Published: August 18, 2025
Osilodrostat-associated Adrenal Gland Shrinkage: a Case Series of Patients with ACTH-Dependent Cushing's Syndrome.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 17, 2025
Last Updated: 02/24/2026